| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coactivator activity | MED12L NCOA3 ARID1B FUS TCF20 KMT2E ARID1A PDLIM1 SS18 SS18L1 | 1.11e-09 | 303 | 45 | 10 | GO:0003713 |
| GeneOntologyMolecularFunction | histone phosphatase activity | 1.07e-08 | 3 | 45 | 3 | GO:0140789 | |
| GeneOntologyMolecularFunction | histone H2AXY142 phosphatase activity | 1.07e-08 | 3 | 45 | 3 | GO:0140793 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | MED12L NCOA3 EWSR1 ARID1B FUS TCF20 KMT2E ARID1A PDLIM1 SS18 SS18L1 | 3.39e-08 | 562 | 45 | 11 | GO:0003712 |
| GeneOntologyMolecularFunction | molecular adaptor activity | MED12L YTHDF1 NCOA3 EWSR1 ARID1B FUS TCF20 KMT2E ARID1A PDLIM1 SS18 YTHDF3 TAB3 SS18L1 HGS | 1.38e-07 | 1356 | 45 | 15 | GO:0060090 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | MED12L YTHDF1 NCOA3 EWSR1 ARID1B FUS TCF20 KMT2E ARID1A PDLIM1 SS18 YTHDF3 SS18L1 HGS | 1.41e-07 | 1160 | 45 | 14 | GO:0030674 |
| GeneOntologyMolecularFunction | poly(A) RNA polymerase activity | 2.32e-06 | 12 | 45 | 3 | GO:1990817 | |
| GeneOntologyMolecularFunction | adenylyltransferase activity | 4.60e-05 | 31 | 45 | 3 | GO:0070566 | |
| GeneOntologyMolecularFunction | histone modifying activity | 1.60e-04 | 229 | 45 | 5 | GO:0140993 | |
| GeneOntologyMolecularFunction | chromatin binding | 2.17e-04 | 739 | 45 | 8 | GO:0003682 | |
| GeneOntologyMolecularFunction | transcription factor binding | 2.46e-04 | 753 | 45 | 8 | GO:0008134 | |
| GeneOntologyMolecularFunction | N6-methyladenosine-containing RNA reader activity | 5.12e-04 | 15 | 45 | 2 | GO:1990247 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 8.22e-04 | 187 | 45 | 4 | GO:0016922 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 1.18e-03 | 206 | 45 | 4 | GO:0140030 | |
| GeneOntologyMolecularFunction | nuclear retinoid X receptor binding | 1.22e-03 | 23 | 45 | 2 | GO:0046965 | |
| GeneOntologyMolecularFunction | protein-RNA adaptor activity | 1.33e-03 | 24 | 45 | 2 | GO:0140517 | |
| GeneOntologyMolecularFunction | protein tyrosine phosphatase activity | 1.62e-03 | 103 | 45 | 3 | GO:0004725 | |
| GeneOntologyMolecularFunction | ubiquitin binding | 1.80e-03 | 107 | 45 | 3 | GO:0043130 | |
| GeneOntologyMolecularFunction | nuclear thyroid hormone receptor binding | 2.66e-03 | 34 | 45 | 2 | GO:0046966 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein binding | 3.00e-03 | 128 | 45 | 3 | GO:0032182 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 3.86e-03 | 140 | 45 | 3 | GO:0001221 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 4.86e-03 | 152 | 45 | 3 | GO:0016779 | |
| GeneOntologyMolecularFunction | nuclear estrogen receptor binding | 6.36e-03 | 53 | 45 | 2 | GO:0030331 | |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 6.84e-03 | 55 | 45 | 2 | GO:0042974 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA repair | 6.52e-07 | 143 | 45 | 6 | GO:0045739 | |
| GeneOntologyBiologicalProcess | regulation of DNA repair | 1.13e-05 | 234 | 45 | 6 | GO:0006282 | |
| GeneOntologyBiologicalProcess | chromatin organization | 1.82e-05 | 896 | 45 | 10 | GO:0006325 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | 2.63e-05 | 741 | 45 | 9 | GO:0006338 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | CDK8 MED12L FOXO1 NCOA3 NKX2-2 EYA1 TCF20 SS18 EBF3 NR1H4 SS18L1 CDON | 2.99e-05 | 1390 | 45 | 12 | GO:0045944 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | 4.60e-05 | 999 | 45 | 10 | GO:0071824 | |
| GeneOntologyBiologicalProcess | stress granule assembly | 6.59e-05 | 36 | 45 | 3 | GO:0034063 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA metabolic process | 8.11e-05 | 333 | 45 | 6 | GO:0051054 | |
| GeneOntologyBiologicalProcess | negative regulation of extrinsic apoptotic signaling pathway in absence of ligand | 9.06e-05 | 40 | 45 | 3 | GO:2001240 | |
| GeneOntologyBiologicalProcess | negative regulation of signal transduction in absence of ligand | 9.06e-05 | 40 | 45 | 3 | GO:1901099 | |
| GeneOntologyBiologicalProcess | cell fate specification | 1.49e-04 | 123 | 45 | 4 | GO:0001708 | |
| GeneOntologyBiologicalProcess | positive regulation of stem cell population maintenance | 1.88e-04 | 51 | 45 | 3 | GO:1902459 | |
| GeneOntologyBiologicalProcess | regulation of extrinsic apoptotic signaling pathway in absence of ligand | 2.23e-04 | 54 | 45 | 3 | GO:2001239 | |
| GeneOntologyBiologicalProcess | positive regulation of myoblast differentiation | 2.23e-04 | 54 | 45 | 3 | GO:0045663 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to stress | 2.90e-04 | 598 | 45 | 7 | GO:0080135 | |
| GeneOntologyBiologicalProcess | mesodermal cell fate specification | 3.58e-04 | 13 | 45 | 2 | GO:0007501 | |
| GeneOntologyBiologicalProcess | protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 4.80e-04 | 15 | 45 | 2 | GO:0043328 | |
| GeneOntologyBiologicalProcess | positive regulation of exosomal secretion | 5.48e-04 | 16 | 45 | 2 | GO:1903543 | |
| GeneOntologyBiologicalProcess | regulation of stem cell population maintenance | 6.58e-04 | 78 | 45 | 3 | GO:2000036 | |
| GeneOntologyBiologicalProcess | double-strand break repair | 6.77e-04 | 324 | 45 | 5 | GO:0006302 | |
| GeneOntologyCellularComponent | npBAF complex | 3.34e-06 | 14 | 45 | 3 | GO:0071564 | |
| GeneOntologyCellularComponent | nBAF complex | 5.12e-06 | 16 | 45 | 3 | GO:0071565 | |
| GeneOntologyCellularComponent | ESCRT-0 complex | 1.36e-05 | 3 | 45 | 2 | GO:0033565 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | CDK8 MED12L PHF1 NCOA3 RANBP2 ARID1B KMT2E ARID1A SS18 UBAP2L NR1H4 SS18L1 | 2.39e-05 | 1377 | 45 | 12 | GO:0140513 |
| GeneOntologyCellularComponent | SWI/SNF complex | 3.63e-05 | 30 | 45 | 3 | GO:0016514 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 5.39e-05 | 96 | 45 | 4 | GO:0070603 | |
| GeneOntologyCellularComponent | ATPase complex | 1.70e-04 | 129 | 45 | 4 | GO:1904949 | |
| GeneOntologyCellularComponent | bBAF complex | 2.02e-04 | 10 | 45 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | chromatin | FOXO1 NCOA3 TSHZ3 ARID1B NKX2-2 KMT2E ARID1A SS18 EBF3 NR1H4 SS18L1 | 2.32e-04 | 1480 | 45 | 11 | GO:0000785 |
| GeneOntologyCellularComponent | brahma complex | 4.06e-04 | 14 | 45 | 2 | GO:0035060 | |
| GeneOntologyCellularComponent | cytoplasmic stress granule | 1.16e-03 | 96 | 45 | 3 | GO:0010494 | |
| GeneOntologyCellularComponent | ESCRT complex | 2.16e-03 | 32 | 45 | 2 | GO:0036452 | |
| GeneOntologyCellularComponent | mediator complex | 2.88e-03 | 37 | 45 | 2 | GO:0016592 | |
| HumanPheno | Abnormal response to social norms | 1.22e-04 | 807 | 18 | 10 | HP:5200123 | |
| HumanPheno | Social disinhibition | 1.22e-04 | 807 | 18 | 10 | HP:5200029 | |
| HumanPheno | Disinhibition | 1.22e-04 | 807 | 18 | 10 | HP:0000734 | |
| HumanPheno | Inappropriate behavior | 1.22e-04 | 807 | 18 | 10 | HP:0000719 | |
| HumanPheno | Hypoplastic toenails | 1.61e-04 | 82 | 18 | 4 | HP:0001800 | |
| HumanPheno | Aggressive behavior | 1.83e-04 | 516 | 18 | 8 | HP:0000718 | |
| HumanPheno | Abnormal aggressive, impulsive or violent behavior | 1.83e-04 | 516 | 18 | 8 | HP:0006919 | |
| HumanPheno | Abnormally increased volition | 2.32e-04 | 869 | 18 | 10 | HP:5200263 | |
| HumanPheno | Aspiration pneumonia | 2.84e-04 | 95 | 18 | 4 | HP:0011951 | |
| HumanPheno | Sandal gap | 2.96e-04 | 96 | 18 | 4 | HP:0001852 | |
| HumanPheno | Hyperactivity | 3.18e-04 | 558 | 18 | 8 | HP:0000752 | |
| HumanPheno | Abnormal social development | 3.38e-04 | 908 | 18 | 10 | HP:0025732 | |
| HumanPheno | Delayed ability to walk | 4.33e-04 | 304 | 18 | 6 | HP:0031936 | |
| HumanPheno | Impairment in personality functioning | CDK8 MED12L ARID1B FUS TCF20 KMT2E ARID1A EBF3 UBAP2L NR1H4 CDON | 4.47e-04 | 1141 | 18 | 11 | HP:0031466 |
| HumanPheno | Prominent fingertip pads | 5.12e-04 | 46 | 18 | 3 | HP:0001212 | |
| HumanPheno | Myopia | 5.17e-04 | 447 | 18 | 7 | HP:0000545 | |
| HumanPheno | Feeding difficulties | CDK8 MED12L ARID1B FUS TCF20 KMT2E ARID1A TFG EBF3 UBAP2L CDON | 5.55e-04 | 1168 | 18 | 11 | HP:0011968 |
| HumanPheno | Prominent digit pad | 5.80e-04 | 48 | 18 | 3 | HP:0011298 | |
| HumanPheno | Aplastic/hypoplastic toenail | 6.31e-04 | 117 | 18 | 4 | HP:0010624 | |
| HumanPheno | Cochlear malformation | 6.37e-04 | 11 | 18 | 2 | HP:0008554 | |
| HumanPheno | Abnormality of upper lip vermillion | 6.49e-04 | 464 | 18 | 7 | HP:0011339 | |
| HumanPheno | Thin upper lip vermilion | 7.77e-04 | 339 | 18 | 6 | HP:0000219 | |
| HumanPheno | Thin lips | 7.77e-04 | 339 | 18 | 6 | HP:0000213 | |
| HumanPheno | Maladaptive fear-related cognitions | 8.29e-04 | 483 | 18 | 7 | HP:5200230 | |
| HumanPheno | Anxiety | 8.29e-04 | 483 | 18 | 7 | HP:0000739 | |
| Domain | - | 1.31e-08 | 3 | 45 | 3 | 3.30.70.590 | |
| Domain | PolyA_polymerase | 1.31e-08 | 3 | 45 | 3 | IPR014492 | |
| Domain | PAP_central | 1.31e-08 | 3 | 45 | 3 | PF04928 | |
| Domain | PAP_RNA-bind | 1.31e-08 | 3 | 45 | 3 | PF04926 | |
| Domain | PolA_pol_cen_dom | 1.31e-08 | 3 | 45 | 3 | IPR007012 | |
| Domain | PolA_pol_RNA-bd_dom | 1.31e-08 | 3 | 45 | 3 | IPR007010 | |
| Domain | NuclTrfase_I_C | 1.31e-08 | 3 | 45 | 3 | IPR011068 | |
| Domain | EYA_fam | 5.22e-08 | 4 | 45 | 3 | IPR028472 | |
| Domain | EYA_dom | 5.22e-08 | 4 | 45 | 3 | IPR006545 | |
| Domain | zf-RanBP | 2.08e-07 | 22 | 45 | 4 | PF00641 | |
| Domain | ZnF_RBZ | 2.52e-07 | 23 | 45 | 4 | SM00547 | |
| Domain | ZF_RANBP2_2 | 2.52e-07 | 23 | 45 | 4 | PS50199 | |
| Domain | ZF_RANBP2_1 | 3.02e-07 | 24 | 45 | 4 | PS01358 | |
| Domain | Znf_RanBP2 | 3.58e-07 | 25 | 45 | 4 | IPR001876 | |
| Domain | NTP_transf_2 | 2.13e-06 | 11 | 45 | 3 | PF01909 | |
| Domain | Polymerase_NTP_transf_dom | 2.13e-06 | 11 | 45 | 3 | IPR002934 | |
| Domain | BAF250_C | 5.68e-06 | 2 | 45 | 2 | IPR033388 | |
| Domain | BAF250_C | 5.68e-06 | 2 | 45 | 2 | PF12031 | |
| Domain | BAF250/Osa | 5.68e-06 | 2 | 45 | 2 | IPR021906 | |
| Domain | SSXT | 1.70e-05 | 3 | 45 | 2 | PF05030 | |
| Domain | SS18_fam | 1.70e-05 | 3 | 45 | 2 | IPR007726 | |
| Domain | YTH | 5.65e-05 | 5 | 45 | 2 | PS50882 | |
| Domain | YTH_domain | 5.65e-05 | 5 | 45 | 2 | IPR007275 | |
| Domain | YTH | 5.65e-05 | 5 | 45 | 2 | PF04146 | |
| Domain | VHS | 2.02e-04 | 9 | 45 | 2 | SM00288 | |
| Domain | VHS_dom | 2.02e-04 | 9 | 45 | 2 | IPR002014 | |
| Domain | VHS | 2.02e-04 | 9 | 45 | 2 | PF00790 | |
| Domain | VHS | 2.02e-04 | 9 | 45 | 2 | PS50179 | |
| Domain | - | 2.52e-04 | 10 | 45 | 2 | 4.10.1060.10 | |
| Domain | Znf_FYVE_PHD | 4.27e-04 | 147 | 45 | 4 | IPR011011 | |
| Domain | - | 5.84e-04 | 15 | 45 | 2 | 1.10.150.60 | |
| Domain | ARID | 5.84e-04 | 15 | 45 | 2 | PF01388 | |
| Domain | BRIGHT | 5.84e-04 | 15 | 45 | 2 | SM00501 | |
| Domain | ARID_dom | 5.84e-04 | 15 | 45 | 2 | IPR001606 | |
| Domain | ARID | 5.84e-04 | 15 | 45 | 2 | PS51011 | |
| Domain | UIM | 8.47e-04 | 18 | 45 | 2 | PF02809 | |
| Domain | UIM | 1.16e-03 | 21 | 45 | 2 | SM00726 | |
| Domain | PHD | 1.28e-03 | 89 | 45 | 3 | SM00249 | |
| Domain | Znf_PHD | 1.37e-03 | 91 | 45 | 3 | IPR001965 | |
| Domain | UIM | 1.51e-03 | 24 | 45 | 2 | PS50330 | |
| Domain | ZF_PHD_2 | 1.55e-03 | 95 | 45 | 3 | PS50016 | |
| Domain | ZF_PHD_1 | 1.60e-03 | 96 | 45 | 3 | PS01359 | |
| Domain | UIM_dom | 1.64e-03 | 25 | 45 | 2 | IPR003903 | |
| Domain | - | 1.78e-03 | 26 | 45 | 2 | 1.25.40.90 | |
| Domain | ENTH_VHS | 2.21e-03 | 29 | 45 | 2 | IPR008942 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION | 2.62e-06 | 42 | 33 | 4 | M48237 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 6.82e-05 | 95 | 33 | 4 | M48268 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS | 7.40e-05 | 97 | 33 | 4 | M48262 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 2.81e-04 | 137 | 33 | 4 | M48232 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 2.87e-04 | 254 | 33 | 5 | M27131 | |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE | 3.14e-04 | 57 | 33 | 3 | MM15298 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | 3.22e-04 | 142 | 33 | 4 | M48257 | |
| Pathway | KEGG_RNA_DEGRADATION | 3.47e-04 | 59 | 33 | 3 | M963 | |
| Pathway | WP_EGFEGFR_SIGNALING | 5.30e-04 | 162 | 33 | 4 | M39334 | |
| Pathway | REACTOME_INLB_MEDIATED_ENTRY_OF_LISTERIA_MONOCYTOGENES_INTO_HOST_CELL | 5.47e-04 | 15 | 33 | 2 | M27774 | |
| Pathway | WP_RUBINSTEINTAYBI_SYNDROME_1 | 5.47e-04 | 15 | 33 | 2 | M48323 | |
| Pathway | WP_MRNA_PROCESSING | 5.51e-04 | 451 | 33 | 6 | MM15946 | |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE | 7.89e-04 | 78 | 33 | 3 | M27589 | |
| Pathway | REACTOME_LISTERIA_MONOCYTOGENES_ENTRY_INTO_HOST_CELLS | 9.83e-04 | 20 | 33 | 2 | M27780 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_MET_ACTIVITY | 1.09e-03 | 21 | 33 | 2 | M27645 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_MET_ACTIVITY | 1.09e-03 | 21 | 33 | 2 | MM15347 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS | 1.09e-03 | 21 | 33 | 2 | M14966 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 1.18e-03 | 1432 | 33 | 10 | M509 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 1.19e-03 | 22 | 33 | 2 | MM1370 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 2.07e-03 | 29 | 33 | 2 | M48076 | |
| Pathway | REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT | 2.37e-03 | 31 | 33 | 2 | M1009 | |
| Pathway | REACTOME_EGFR_DOWNREGULATION | 2.37e-03 | 31 | 33 | 2 | MM14705 | |
| Pathway | WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1 | 2.37e-03 | 31 | 33 | 2 | M39522 | |
| Pathway | REACTOME_EGFR_DOWNREGULATION | 2.37e-03 | 31 | 33 | 2 | M16597 | |
| Pathway | REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT | 2.37e-03 | 31 | 33 | 2 | MM15637 | |
| Pathway | WP_PREGNANE_X_RECEPTOR_PATHWAY | 2.52e-03 | 32 | 33 | 2 | M39567 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 2.60e-03 | 118 | 33 | 3 | M27316 | |
| Pubmed | FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex. | 9.53e-11 | 23 | 45 | 5 | 30962207 | |
| Pubmed | YTHDF1 NCOA3 TSHZ3 EWSR1 ARID1B LASP1 EYA3 TCF20 ARID1A SS18 UBAP2L YTHDF3 TAB3 SS18L1 HGS | 1.61e-10 | 1429 | 45 | 15 | 35140242 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | YTHDF1 TOR1AIP2 NCOA3 EWSR1 ARID1B FUS TCF20 ARID1A TFG YTHDF3 | 2.94e-10 | 457 | 45 | 10 | 32344865 |
| Pubmed | Eyes absent represents a class of protein tyrosine phosphatases. | 2.02e-09 | 3 | 45 | 3 | 14628052 | |
| Pubmed | 2.02e-09 | 3 | 45 | 3 | 9020840 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | YTHDF1 RANBP2 EWSR1 ARID1B FUS ILF3 TCF20 ARID1A SS18 UBAP2L YTHDF3 SS18L1 | 2.12e-09 | 954 | 45 | 12 | 36373674 |
| Pubmed | 3.30e-09 | 15 | 45 | 4 | 23785148 | ||
| Pubmed | Characterization of TFG in mus musculus and Caenorhabditis elegans. | 8.09e-09 | 4 | 45 | 3 | 10092511 | |
| Pubmed | 8.09e-09 | 4 | 45 | 3 | 8491200 | ||
| Pubmed | Misexpression of the eyes absent family triggers the apoptotic program. | 8.09e-09 | 4 | 45 | 3 | 11700312 | |
| Pubmed | 8.32e-09 | 472 | 45 | 9 | 38943005 | ||
| Pubmed | CDK8 NCOA3 RANBP2 EWSR1 ARID1B LASP1 FUS ILF3 EYA3 TCF20 ARID1A EBF3 | 1.07e-08 | 1103 | 45 | 12 | 34189442 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | PHF1 PAPOLB NCOA3 EWSR1 NKX2-2 EYA2 EYA3 TCF20 EBF3 SS18L1 PAPOLG | 1.14e-08 | 877 | 45 | 11 | 20211142 |
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.55e-08 | 351 | 45 | 8 | 38297188 | |
| Pubmed | 2.02e-08 | 5 | 45 | 3 | 9006082 | ||
| Pubmed | Cooperation of six and eya in activation of their target genes through nuclear translocation of Eya. | 2.02e-08 | 5 | 45 | 3 | 10490620 | |
| Pubmed | 2.02e-08 | 5 | 45 | 3 | 9195991 | ||
| Pubmed | EYA4, a novel vertebrate gene related to Drosophila eyes absent. | 4.04e-08 | 6 | 45 | 3 | 9887327 | |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 4.07e-08 | 258 | 45 | 7 | 37794589 | |
| Pubmed | 4.40e-08 | 261 | 45 | 7 | 33277362 | ||
| Pubmed | 7.06e-08 | 7 | 45 | 3 | 23540691 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 9.44e-08 | 444 | 45 | 8 | 34795231 | |
| Pubmed | 1.10e-07 | 453 | 45 | 8 | 29656893 | ||
| Pubmed | 4.42e-07 | 12 | 45 | 3 | 11734557 | ||
| Pubmed | Rescue of deficits by Brwd1 copy number restoration in the Ts65Dn mouse model of Down syndrome. | 7.29e-07 | 14 | 45 | 3 | 36289231 | |
| Pubmed | 1.11e-06 | 421 | 45 | 7 | 34650049 | ||
| Pubmed | 1.12e-06 | 263 | 45 | 6 | 34702444 | ||
| Pubmed | 1.18e-06 | 425 | 45 | 7 | 24999758 | ||
| Pubmed | 1.45e-06 | 638 | 45 | 8 | 31182584 | ||
| Pubmed | 1.56e-06 | 65 | 45 | 4 | 26655900 | ||
| Pubmed | 1.63e-06 | 18 | 45 | 3 | 26674342 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 31392992 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 34386776 | ||
| Pubmed | Regulation of spermatogenesis by testis-specific, cytoplasmic poly(A) polymerase TPAP. | 1.64e-06 | 2 | 45 | 2 | 12471261 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 28106076 | ||
| Pubmed | Deletion of YTHDF1 (not YTHDF3) reduced brain and gut damage after traumatic brain injury. | 1.64e-06 | 2 | 45 | 2 | 39081030 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 23202128 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 33890484 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 25296754 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 8921363 | ||
| Pubmed | ARID1B is a specific vulnerability in ARID1A-mutant cancers. | 1.64e-06 | 2 | 45 | 2 | 24562383 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 26573619 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 9407053 | ||
| Pubmed | Dissecting the role of SWI/SNF component ARID1B in steady-state hematopoiesis. | 1.64e-06 | 2 | 45 | 2 | 37611161 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 32791957 | ||
| Pubmed | ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma. | 1.64e-06 | 2 | 45 | 2 | 29890703 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 22982887 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 20660338 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 24788099 | ||
| Pubmed | Chromatin accessibility underlies synthetic lethality of SWI/SNF subunits in ARID1A-mutant cancers. | 1.64e-06 | 2 | 45 | 2 | 28967863 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 33052929 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 15640163 | ||
| Pubmed | Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas. | 1.64e-06 | 2 | 45 | 2 | 27562491 | |
| Pubmed | Common origin of the human synovial sarcoma associated SS18 and SS18L1 gene loci. | 1.64e-06 | 2 | 45 | 2 | 16484776 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 31994243 | ||
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 1.69e-06 | 154 | 45 | 5 | 16055720 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 1.72e-06 | 283 | 45 | 6 | 30585729 | |
| Pubmed | Histone-binding of DPF2 mediates its repressive role in myeloid differentiation. | 1.72e-06 | 283 | 45 | 6 | 28533407 | |
| Pubmed | 1.86e-06 | 157 | 45 | 5 | 30186101 | ||
| Pubmed | m6A regulation of cortical and retinal neurogenesis is mediated by the redundant m6A readers YTHDFs. | 1.93e-06 | 19 | 45 | 3 | 36039295 | |
| Pubmed | 2.26e-06 | 469 | 45 | 7 | 27634302 | ||
| Pubmed | 3.25e-06 | 78 | 45 | 4 | 28611094 | ||
| Pubmed | 3.44e-06 | 1247 | 45 | 10 | 27684187 | ||
| Pubmed | 3.74e-06 | 725 | 45 | 8 | 27025967 | ||
| Pubmed | 4.17e-06 | 83 | 45 | 4 | 28794006 | ||
| Pubmed | 4.85e-06 | 191 | 45 | 5 | 31177093 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 33432679 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 19351884 | ||
| Pubmed | YTHDF3 facilitates translation and decay of N6-methyladenosine-modified RNA. | 4.91e-06 | 3 | 45 | 2 | 28106072 | |
| Pubmed | FUS-NFATC2 or EWSR1-NFATC2 Fusions Are Present in a Large Proportion of Simple Bone Cysts. | 4.91e-06 | 3 | 45 | 2 | 32991339 | |
| Pubmed | Hybrid structural model of the complete human ESCRT-0 complex. | 4.91e-06 | 3 | 45 | 2 | 19278655 | |
| Pubmed | YTHDF2 suppresses the plasmablast genetic program and promotes germinal center formation. | 4.91e-06 | 3 | 45 | 2 | 35508130 | |
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 21647563 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 18620564 | ||
| Pubmed | A Unified Model for the Function of YTHDF Proteins in Regulating m6A-Modified mRNA. | 4.91e-06 | 3 | 45 | 2 | 32492408 | |
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 9342347 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 34044070 | ||
| Pubmed | Genome-Wide Transcriptional Regulation Mediated by Biochemically Distinct SWI/SNF Complexes. | 4.91e-06 | 3 | 45 | 2 | 26716708 | |
| Pubmed | mRNA and protein levels of FUS, EWSR1, and TAF15 are upregulated in liposarcoma. | 4.91e-06 | 3 | 45 | 2 | 21344536 | |
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 15113837 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 23975937 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 28505004 | ||
| Pubmed | Aggregation of FET Proteins as a Pathological Change in Amyotrophic Lateral Sclerosis. | 4.91e-06 | 3 | 45 | 2 | 27311318 | |
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 31292544 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 21856723 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 33859361 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 27415968 | ||
| Pubmed | Novel FUS-KLF17 and EWSR1-KLF17 fusions in myoepithelial tumors. | 4.91e-06 | 3 | 45 | 2 | 25706482 | |
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 18414662 | ||
| Pubmed | Six and Eya expression during human somitogenesis and MyoD gene family activation. | 4.91e-06 | 3 | 45 | 2 | 12500905 | |
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 13679051 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 26690869 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 34497675 | ||
| Pubmed | Complex alternative RNA processing generates an unexpected diversity of poly(A) polymerase isoforms. | 4.91e-06 | 3 | 45 | 2 | 8628305 | |
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 34049318 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 27903134 | ||
| Pubmed | Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome. | 4.91e-06 | 3 | 45 | 2 | 22426308 | |
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 24382590 | ||
| Pubmed | FOXO1 is a direct target of EWS-Fli1 oncogenic fusion protein in Ewing's sarcoma cells. | 4.91e-06 | 3 | 45 | 2 | 20933505 | |
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 16926188 | ||
| Interaction | NUP35 interactions | YTHDF1 NCOA3 RANBP2 EWSR1 ARID1B FUS ILF3 TCF20 ARID1A TFG YTHDF3 | 1.68e-09 | 424 | 45 | 11 | int:NUP35 |
| Interaction | TLE3 interactions | 8.09e-09 | 376 | 45 | 10 | int:TLE3 | |
| Interaction | PAX9 interactions | 1.46e-08 | 130 | 45 | 7 | int:PAX9 | |
| Interaction | FAM168A interactions | 2.70e-08 | 142 | 45 | 7 | int:FAM168A | |
| Interaction | RBPMS interactions | 5.17e-08 | 340 | 45 | 9 | int:RBPMS | |
| Interaction | SMARCA4 interactions | 5.66e-08 | 462 | 45 | 10 | int:SMARCA4 | |
| Interaction | SOX17 interactions | 6.57e-08 | 95 | 45 | 6 | int:SOX17 | |
| Interaction | SMARCC2 interactions | 7.13e-08 | 353 | 45 | 9 | int:SMARCC2 | |
| Interaction | CSTF2 interactions | 7.58e-08 | 165 | 45 | 7 | int:CSTF2 | |
| Interaction | SMARCC1 interactions | 1.46e-07 | 384 | 45 | 9 | int:SMARCC1 | |
| Interaction | ALG13 interactions | 1.54e-07 | 183 | 45 | 7 | int:ALG13 | |
| Interaction | TBXT interactions | 2.17e-07 | 116 | 45 | 6 | int:TBXT | |
| Interaction | FLI1 interactions | 2.60e-07 | 62 | 45 | 5 | int:FLI1 | |
| Interaction | PAX7 interactions | 3.22e-07 | 124 | 45 | 6 | int:PAX7 | |
| Interaction | SP7 interactions | 3.25e-07 | 304 | 45 | 8 | int:SP7 | |
| Interaction | BICRA interactions | 3.85e-07 | 67 | 45 | 5 | int:BICRA | |
| Interaction | GCM1 interactions | 4.14e-07 | 68 | 45 | 5 | int:GCM1 | |
| Interaction | SMG7 interactions | 4.68e-07 | 319 | 45 | 8 | int:SMG7 | |
| Interaction | ERG interactions | 5.87e-07 | 223 | 45 | 7 | int:ERG | |
| Interaction | VPS37C interactions | 6.86e-07 | 141 | 45 | 6 | int:VPS37C | |
| Interaction | SOX7 interactions | 1.06e-06 | 82 | 45 | 5 | int:SOX7 | |
| Interaction | IRF4 interactions | 1.27e-06 | 85 | 45 | 5 | int:IRF4 | |
| Interaction | SMC5 interactions | YTHDF1 RANBP2 EWSR1 ARID1B FUS ILF3 TCF20 ARID1A SS18 UBAP2L YTHDF3 SS18L1 | 1.31e-06 | 1000 | 45 | 12 | int:SMC5 |
| Interaction | CRX interactions | 1.40e-06 | 254 | 45 | 7 | int:CRX | |
| Interaction | SS18 interactions | 1.51e-06 | 88 | 45 | 5 | int:SS18 | |
| Interaction | MED25 interactions | 1.98e-06 | 93 | 45 | 5 | int:MED25 | |
| Interaction | UBAP2 interactions | 2.05e-06 | 170 | 45 | 6 | int:UBAP2 | |
| Interaction | DMRTB1 interactions | 2.09e-06 | 94 | 45 | 5 | int:DMRTB1 | |
| Interaction | DPF1 interactions | 2.20e-06 | 95 | 45 | 5 | int:DPF1 | |
| Interaction | TP53BP1 interactions | 2.25e-06 | 533 | 45 | 9 | int:TP53BP1 | |
| Interaction | FMR1 interactions | 2.35e-06 | 536 | 45 | 9 | int:FMR1 | |
| Interaction | ARID1A interactions | 2.44e-06 | 276 | 45 | 7 | int:ARID1A | |
| Interaction | SS18L1 interactions | 2.57e-06 | 98 | 45 | 5 | int:SS18L1 | |
| Interaction | ARID1B interactions | 2.58e-06 | 177 | 45 | 6 | int:ARID1B | |
| Interaction | PPIA interactions | 2.93e-06 | 888 | 45 | 11 | int:PPIA | |
| Interaction | MAPK1IP1L interactions | 3.02e-06 | 45 | 45 | 4 | int:MAPK1IP1L | |
| Interaction | CELF1 interactions | 3.23e-06 | 288 | 45 | 7 | int:CELF1 | |
| Interaction | TLX3 interactions | 3.45e-06 | 291 | 45 | 7 | int:TLX3 | |
| Interaction | CSTF2T interactions | 3.61e-06 | 105 | 45 | 5 | int:CSTF2T | |
| Interaction | SMARCD3 interactions | 3.96e-06 | 107 | 45 | 5 | int:SMARCD3 | |
| Interaction | CREBBP interactions | 5.81e-06 | 599 | 45 | 9 | int:CREBBP | |
| Interaction | DDIT3 interactions | 6.95e-06 | 120 | 45 | 5 | int:DDIT3 | |
| Interaction | EYA2 interactions | 7.24e-06 | 121 | 45 | 5 | int:EYA2 | |
| Interaction | PRMT5 interactions | 8.46e-06 | 471 | 45 | 8 | int:PRMT5 | |
| Interaction | SOX2 interactions | YTHDF1 NCOA3 RANBP2 TSHZ3 EWSR1 ARID1B FUS ILF3 EYA1 TCF20 ARID1A PDLIM1 SS18 | 8.79e-06 | 1422 | 45 | 13 | int:SOX2 |
| Interaction | SNRNP40 interactions | 9.53e-06 | 637 | 45 | 9 | int:SNRNP40 | |
| Interaction | RARA interactions | 9.75e-06 | 223 | 45 | 6 | int:RARA | |
| Interaction | SUZ12 interactions | 1.04e-05 | 644 | 45 | 9 | int:SUZ12 | |
| Interaction | CEBPA interactions | CDK8 NCOA3 RANBP2 EWSR1 ARID1B LASP1 FUS ILF3 EYA3 TCF20 ARID1A EBF3 | 1.25e-05 | 1245 | 45 | 12 | int:CEBPA |
| Interaction | PHF10 interactions | 1.42e-05 | 139 | 45 | 5 | int:PHF10 | |
| Interaction | SMARCB1 interactions | 1.49e-05 | 364 | 45 | 7 | int:SMARCB1 | |
| Interaction | C14orf119 interactions | 1.50e-05 | 67 | 45 | 4 | int:C14orf119 | |
| Interaction | SMAD1 interactions | 1.59e-05 | 243 | 45 | 6 | int:SMAD1 | |
| Interaction | ETV4 interactions | 1.69e-05 | 69 | 45 | 4 | int:ETV4 | |
| Interaction | CTDSPL2 interactions | 1.79e-05 | 70 | 45 | 4 | int:CTDSPL2 | |
| Interaction | ELF5 interactions | 1.86e-05 | 147 | 45 | 5 | int:ELF5 | |
| Interaction | ARID2 interactions | 2.26e-05 | 153 | 45 | 5 | int:ARID2 | |
| Interaction | EWSR1 interactions | 2.44e-05 | 906 | 45 | 10 | int:EWSR1 | |
| Interaction | RNU5B-1 interactions | 2.92e-05 | 4 | 45 | 2 | int:RNU5B-1 | |
| Interaction | SAXO4 interactions | 3.03e-05 | 80 | 45 | 4 | int:SAXO4 | |
| Interaction | HNF4A interactions | 3.19e-05 | 275 | 45 | 6 | int:HNF4A | |
| Interaction | BICC1 interactions | 3.28e-05 | 28 | 45 | 3 | int:BICC1 | |
| Interaction | MYCN interactions | YTHDF1 EWSR1 ARID1B FUS ILF3 TCF20 ARID1A TFG SS18 UBAP2L YTHDF3 SS18L1 | 3.33e-05 | 1373 | 45 | 12 | int:MYCN |
| Interaction | STK11IP interactions | 3.50e-05 | 83 | 45 | 4 | int:STK11IP | |
| Interaction | CEP85 interactions | 3.64e-05 | 169 | 45 | 5 | int:CEP85 | |
| Interaction | EPHA8 interactions | 3.64e-05 | 169 | 45 | 5 | int:EPHA8 | |
| Interaction | SIX2 interactions | 3.65e-05 | 29 | 45 | 3 | int:SIX2 | |
| Interaction | MED30 interactions | 3.67e-05 | 84 | 45 | 4 | int:MED30 | |
| Interaction | R3HDM1 interactions | 3.67e-05 | 84 | 45 | 4 | int:R3HDM1 | |
| Interaction | SMARCE1 interactions | 4.04e-05 | 287 | 45 | 6 | int:SMARCE1 | |
| Interaction | RNF43 interactions | 4.13e-05 | 427 | 45 | 7 | int:RNF43 | |
| Interaction | TLX1 interactions | 4.30e-05 | 175 | 45 | 5 | int:TLX1 | |
| Interaction | CUL2 interactions | 4.32e-05 | 591 | 45 | 8 | int:CUL2 | |
| Interaction | UBAP2L interactions | 4.99e-05 | 298 | 45 | 6 | int:UBAP2L | |
| Interaction | HNRNPF interactions | 5.21e-05 | 607 | 45 | 8 | int:HNRNPF | |
| Interaction | FOXI1 interactions | 5.25e-05 | 92 | 45 | 4 | int:FOXI1 | |
| Interaction | CEBPB interactions | CDK8 YTHDF1 FOXO1 RANBP2 TSHZ3 EWSR1 NKX2-2 LASP1 ILF3 TCF20 UBAP2L YTHDF3 | 5.42e-05 | 1443 | 45 | 12 | int:CEBPB |
| Interaction | SMAD3 interactions | 5.52e-05 | 447 | 45 | 7 | int:SMAD3 | |
| Interaction | UBQLN2 interactions | 5.57e-05 | 797 | 45 | 9 | int:UBQLN2 | |
| Interaction | KRTAP26-1 interactions | 5.71e-05 | 94 | 45 | 4 | int:KRTAP26-1 | |
| Interaction | DPF3 interactions | 5.95e-05 | 95 | 45 | 4 | int:DPF3 | |
| Interaction | BCL7B interactions | 5.95e-05 | 95 | 45 | 4 | int:BCL7B | |
| Interaction | TRIM31 interactions | 6.09e-05 | 454 | 45 | 7 | int:TRIM31 | |
| Interaction | MYOD1 interactions | 7.02e-05 | 194 | 45 | 5 | int:MYOD1 | |
| Interaction | KLF5 interactions | 7.19e-05 | 195 | 45 | 5 | int:KLF5 | |
| Interaction | WWP2 interactions | 8.35e-05 | 840 | 45 | 9 | int:WWP2 | |
| Interaction | DACH1 interactions | 8.47e-05 | 104 | 45 | 4 | int:DACH1 | |
| Interaction | FEV interactions | 8.69e-05 | 203 | 45 | 5 | int:FEV | |
| Interaction | DTX2 interactions | 8.76e-05 | 330 | 45 | 6 | int:DTX2 | |
| Interaction | BMI1 interactions | 9.26e-05 | 659 | 45 | 8 | int:BMI1 | |
| Interaction | NR5A2 interactions | 1.05e-04 | 41 | 45 | 3 | int:NR5A2 | |
| Interaction | SF3B4 interactions | 1.07e-04 | 342 | 45 | 6 | int:SF3B4 | |
| Interaction | TDRD3 interactions | 1.07e-04 | 212 | 45 | 5 | int:TDRD3 | |
| Interaction | PAX8 interactions | 1.09e-04 | 111 | 45 | 4 | int:PAX8 | |
| Interaction | DPF2 interactions | 1.19e-04 | 349 | 45 | 6 | int:DPF2 | |
| Interaction | SMARCD1 interactions | 1.19e-04 | 349 | 45 | 6 | int:SMARCD1 | |
| Interaction | BCL7C interactions | 1.25e-04 | 115 | 45 | 4 | int:BCL7C | |
| Interaction | BRD9 interactions | 1.34e-04 | 117 | 45 | 4 | int:BRD9 | |
| Interaction | PSMB11 interactions | 1.35e-04 | 8 | 45 | 2 | int:PSMB11 | |
| Interaction | PABPC1 interactions | 1.39e-04 | 699 | 45 | 8 | int:PABPC1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr20q13 | 7.79e-04 | 422 | 45 | 4 | chr20q13 | |
| GeneFamily | EYA transcriptional coactivator and phosphatases | 1.33e-08 | 4 | 28 | 3 | 1044 | |
| GeneFamily | Zinc fingers RANBP2-type |RNA binding motif containing | 2.70e-08 | 21 | 28 | 4 | 89 | |
| GeneFamily | ESCRT-0 | 6.93e-06 | 3 | 28 | 2 | 1115 | |
| GeneFamily | AT-rich interaction domain containing | 2.40e-04 | 15 | 28 | 2 | 418 | |
| GeneFamily | Cyclins|Mediator complex | 1.19e-03 | 33 | 28 | 2 | 1061 | |
| GeneFamily | LIM domain containing | 3.75e-03 | 59 | 28 | 2 | 1218 | |
| GeneFamily | PHD finger proteins | 8.52e-03 | 90 | 28 | 2 | 88 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | 6.45e-07 | 432 | 45 | 8 | M41149 | |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | 1.23e-06 | 323 | 45 | 7 | M9150 | |
| Coexpression | DOUGLAS_BMI1_TARGETS_UP | 4.62e-06 | 563 | 45 | 8 | M15103 | |
| Coexpression | GSE27896_HDAC6_KO_VS_WT_TREG_UP | 1.27e-05 | 176 | 45 | 5 | M8248 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | 1.82e-05 | 680 | 45 | 8 | M41089 | |
| Coexpression | TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_MESENCHYMAL_STEM_CELL_OF_ADIPOSE_AGEING | 1.92e-05 | 685 | 45 | 8 | MM3782 | |
| Coexpression | GSE15733_BM_VS_SPLEEN_MEMORY_CD4_TCELL_DN | 2.29e-05 | 199 | 45 | 5 | M3569 | |
| Coexpression | GSE17721_0.5H_VS_4H_CPG_BMDC_DN | 2.35e-05 | 200 | 45 | 5 | M4125 | |
| Coexpression | XIE_TRASTUZUMAB_CARDIOTOXICITY_MMU_MIR_329_3P_GENES | 2.98e-05 | 35 | 45 | 3 | MM17501 | |
| Coexpression | GENTILE_UV_RESPONSE_CLUSTER_D5 | 2.98e-05 | 35 | 45 | 3 | M13814 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | 4.55e-05 | 1009 | 45 | 9 | M157 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN | 9.87e-05 | 438 | 45 | 6 | M227 | |
| Coexpression | ZHOU_PANCREATIC_BETA_CELL | 1.57e-04 | 11 | 45 | 2 | MM1247 | |
| Coexpression | ZHOU_PANCREATIC_BETA_CELL | 1.57e-04 | 11 | 45 | 2 | M1863 | |
| Coexpression | BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN | 1.64e-04 | 160 | 45 | 4 | M9556 | |
| Coexpression | GSE37301_HEMATOPOIETIC_STEM_CELL_VS_RAG2_KO_NK_CELL_UP | 2.26e-04 | 174 | 45 | 4 | M8885 | |
| Coexpression | GSE3565_CTRL_VS_LPS_INJECTED_SPLENOCYTES_DN | 2.31e-04 | 175 | 45 | 4 | M6328 | |
| Coexpression | BENPORATH_NOS_TARGETS | 2.52e-04 | 179 | 45 | 4 | M14573 | |
| Coexpression | XIE_TRASTUZUMAB_CARDIOTOXICITY_MMU_MIR_669C_3P_GENES | 2.74e-04 | 183 | 45 | 4 | MM17506 | |
| Coexpression | GSE5099_DAY3_VS_DAY7_MCSF_TREATED_MACROPHAGE_DN | 2.80e-04 | 184 | 45 | 4 | M6593 | |
| Coexpression | GSE16385_IFNG_TNF_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP | 2.91e-04 | 186 | 45 | 4 | M8012 | |
| Coexpression | HEVNER_VENTRICULAR_ZONE_AND_UP_NEURON_FATE_COMMITTED_CELLS | 2.98e-04 | 15 | 45 | 2 | MM410 | |
| Coexpression | GSE21927_SPLENIC_VS_TUMOR_MONOCYTES_FROM_C26GM_TUMOROUS_MICE_BALBC_UP | 3.42e-04 | 194 | 45 | 4 | M7587 | |
| Coexpression | GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_UP | 3.55e-04 | 196 | 45 | 4 | M4928 | |
| Coexpression | GSE20152_SPHK1_KO_VS_HTNFA_OVEREXPRESS_ANKLE_UP | 3.62e-04 | 197 | 45 | 4 | M7682 | |
| Coexpression | GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_2H_UP | 3.62e-04 | 197 | 45 | 4 | M6125 | |
| Coexpression | GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_DN | 3.69e-04 | 198 | 45 | 4 | M4446 | |
| Coexpression | GSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_UP | 3.76e-04 | 199 | 45 | 4 | M3257 | |
| Coexpression | GSE43863_DAY6_EFF_VS_DAY150_MEM_TFH_CD4_TCELL_UP | 3.76e-04 | 199 | 45 | 4 | M9745 | |
| Coexpression | GSE15767_MED_VS_SCS_MAC_LN_DN | 3.76e-04 | 199 | 45 | 4 | M3585 | |
| Coexpression | GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_UP | 3.76e-04 | 199 | 45 | 4 | M6194 | |
| Coexpression | GSE43863_DAY6_EFF_VS_DAY150_MEM_LY6C_INT_CXCR5POS_CD4_TCELL_UP | 3.84e-04 | 200 | 45 | 4 | M9748 | |
| Coexpression | GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_CD8_TCELL_UP | 3.84e-04 | 200 | 45 | 4 | M3587 | |
| Coexpression | GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_IL12_CD8_TCELL_UP | 3.84e-04 | 200 | 45 | 4 | M3589 | |
| Coexpression | GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_INFAB_CD8_TCELL_UP | 3.84e-04 | 200 | 45 | 4 | M3593 | |
| Coexpression | GSE5099_MONOCYTE_VS_CLASSICAL_M1_MACROPHAGE_DN | 3.84e-04 | 200 | 45 | 4 | M6587 | |
| Coexpression | GSE39152_BRAIN_VS_SPLEEN_CD103_NEG_MEMORY_CD8_TCELL_UP | 3.84e-04 | 200 | 45 | 4 | M9075 | |
| Coexpression | GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IL12_CD8_TCELL_UP | 3.84e-04 | 200 | 45 | 4 | M3608 | |
| Coexpression | GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IFNAB_CD8_TCELL_UP | 3.84e-04 | 200 | 45 | 4 | M3612 | |
| Coexpression | GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_MIR155_KO_UP | 3.84e-04 | 200 | 45 | 4 | M9776 | |
| Coexpression | GSE37301_LYMPHOID_PRIMED_MPP_VS_COMMON_LYMPHOID_PROGENITOR_DN | 3.84e-04 | 200 | 45 | 4 | M8854 | |
| Coexpression | GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_2H_UP | 3.84e-04 | 200 | 45 | 4 | M6094 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500 | 8.32e-06 | 495 | 45 | 8 | Facebase_RNAseq_e10.5_Olfactory Pit_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500_k-means-cluster#1 | 6.93e-05 | 104 | 45 | 4 | Facebase_RNAseq_e10.5_Olfactory Pit_500_K1 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.22e-06 | 186 | 45 | 5 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.22e-06 | 186 | 45 | 5 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | droplet-Marrow-BM-1m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-06 | 195 | 45 | 5 | 637b06ef3967b03f7165d102d316e8b7161a817d | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.05e-05 | 135 | 45 | 4 | b7a792a7c0c22d8b703509f134115f0e394d7de0 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 2.37e-05 | 166 | 45 | 4 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | Control-Epithelial_cells-Airway_basal|Control / group, cell type (main and fine annotations) | 2.66e-05 | 171 | 45 | 4 | 3965ced4be6db14265a90673502fceee425837ca | |
| ToppCell | Adult-Epithelial-basal_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.84e-05 | 174 | 45 | 4 | a4f98afe7d1cc2617f6f7bc8092c41df57474b30 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.04e-05 | 177 | 45 | 4 | ce86dfaeb74d995a19aea62f0fb15c4c0bb854b0 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.04e-05 | 177 | 45 | 4 | cbad1a23851151dbef01ea2af960e6f0944f838b | |
| ToppCell | Adult-Epithelial-club_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.77e-05 | 187 | 45 | 4 | ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-B_cells-LZ_GC_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.44e-05 | 195 | 45 | 4 | cccc9c70bb8f6df8c6ab94534c17475af1d3e224 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.62e-05 | 197 | 45 | 4 | 1e915957ea6a4550ecb9d6ee4b232aa5800faf20 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.71e-05 | 198 | 45 | 4 | 5374b0e98d669f36a0571d3c006c7bd5e3c8e87f | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pre_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.80e-05 | 199 | 45 | 4 | dd94e42b62af7cbd69c472681d3c758552694ae2 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.80e-05 | 199 | 45 | 4 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW10|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 4.80e-05 | 199 | 45 | 4 | 8e72efcd421639ac36ed036ee13f13de070d361f | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.80e-05 | 199 | 45 | 4 | f5c3561744e2a0e7716657cb521acb1d8f054b41 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 4.89e-05 | 200 | 45 | 4 | 0350e5ffd36033099b7e32a1fdd790fff99790dc | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.89e-05 | 200 | 45 | 4 | 8827653738a931e4a4545e0c7d75be12bed40740 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 4.89e-05 | 200 | 45 | 4 | ad2a6da0b1ae7a9212a3c91e5eec4baa7481d8dc | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-CR-CR_Lhx5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.03e-05 | 86 | 45 | 3 | 2990429ed4438f41ff03f4a9cae8863a528fdd81 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-CR|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.03e-05 | 86 | 45 | 3 | 97467708c90a4bd49deafe3e2ec495c56b448ce1 | |
| Disease | eye disease (implicated_via_orthology) | 6.17e-08 | 6 | 44 | 3 | DOID:5614 (implicated_via_orthology) | |
| Disease | branchiootorenal syndrome (implicated_via_orthology) | 1.08e-07 | 7 | 44 | 3 | DOID:14702 (implicated_via_orthology) | |
| Disease | amyotrophic lateral sclerosis type 6 (implicated_via_orthology) | 6.51e-06 | 3 | 44 | 2 | DOID:0060198 (implicated_via_orthology) | |
| Disease | Extraskeletal Myxoid Chondrosarcoma | 2.17e-05 | 5 | 44 | 2 | C1275278 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 2.17e-05 | 5 | 44 | 2 | C3281201 | |
| Disease | neuroblastoma (is_implicated_in) | 9.71e-05 | 10 | 44 | 2 | DOID:769 (is_implicated_in) | |
| Disease | frontotemporal dementia (implicated_via_orthology) | 1.42e-04 | 12 | 44 | 2 | DOID:9255 (implicated_via_orthology) | |
| Disease | cholangiocarcinoma (biomarker_via_orthology) | 1.68e-04 | 13 | 44 | 2 | DOID:4947 (biomarker_via_orthology) | |
| Disease | Coffin-Siris syndrome | 1.68e-04 | 13 | 44 | 2 | C0265338 | |
| Disease | Abnormal behavior | 2.57e-04 | 16 | 44 | 2 | C0233514 | |
| Disease | disease of metabolism (implicated_via_orthology) | 4.48e-04 | 21 | 44 | 2 | DOID:0014667 (implicated_via_orthology) | |
| Disease | Intellectual Disability | 5.21e-04 | 447 | 44 | 5 | C3714756 | |
| Disease | allergic disease | 5.89e-04 | 258 | 44 | 4 | MONDO_0005271 | |
| Disease | amyotrophic lateral sclerosis (implicated_via_orthology) | 9.21e-04 | 30 | 44 | 2 | DOID:332 (implicated_via_orthology) | |
| Disease | eicosapentaenoic acid measurement | 9.83e-04 | 31 | 44 | 2 | EFO_0007760 | |
| Disease | Global developmental delay | 1.04e-03 | 133 | 44 | 3 | C0557874 | |
| Disease | lysophosphatidylcholine 20:4 measurement | 1.05e-03 | 32 | 44 | 2 | EFO_0010363 | |
| Disease | posterior thigh muscle fat infiltration measurement | 1.25e-03 | 35 | 44 | 2 | EFO_0020934 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YTAQPTQGYAQTTQA | 21 | Q01844 | |
| QNTYGQPSSYGQQSS | 211 | Q01844 | |
| QPSSYGQQSSYGQQS | 216 | Q01844 | |
| PSQYSQQSSSYGQQS | 251 | Q01844 | |
| LSPNYPQNYTSGQIC | 1631 | Q7Z408 | |
| QAQYLPSQSQQRYQP | 696 | Q8NFD5 | |
| QYHPSNNGEYQSSGP | 136 | Q63HQ0 | |
| YFNYNVQQTSTNPPL | 961 | P49792 | |
| SETAYPGQTQYQTLQ | 86 | Q99504 | |
| PGQTQYQTLQQTQPY | 91 | Q99504 | |
| YSQYSNVQFPQVQPQ | 56 | Q96RI1 | |
| YSQPQAQSPYQQQQP | 551 | O14497 | |
| IITPAYPQQNSTYNV | 316 | Q9NRJ5 | |
| NYEQANATLNQYPPS | 4941 | Q99102 | |
| QPSGYVQQQASPYLQ | 1991 | Q86YW9 | |
| AYPTQPGQGYSQQSS | 16 | P35637 | |
| SQQSSQPYGQQSYSG | 26 | P35637 | |
| SYGQPQSGSYSQQPS | 121 | P35637 | |
| QSGSYSQQPSYGGQQ | 126 | P35637 | |
| PPQGYGQQNQYNSSS | 151 | P35637 | |
| YQQPQQQPVAQSYGG | 171 | Q14847 | |
| SQQDYPSYPSFGQGQ | 211 | Q99502 | |
| PPSSSYYQNQQPSAN | 1551 | Q8IZD2 | |
| NDNPPQSSQSSYDVY | 451 | Q9UN70 | |
| ITPAYPQQNSTYNVS | 316 | P51003 | |
| TPAYPQQNSTYNVST | 316 | Q9BWT3 | |
| NTSLNSPSPNYQKYT | 411 | Q12778 | |
| PSSNNNTPIQGFYIY | 851 | Q4KMG0 | |
| SHQGQQQSYNQSPYS | 751 | Q12906 | |
| QQSYNQSPYSNYGPP | 756 | Q12906 | |
| NQPYYSNTPAGLQKN | 806 | Q9NRM1 | |
| GYVPSSTPQQSNYNT | 471 | Q9H4W6 | |
| GYSATSQQPPQYSHQ | 446 | P49336 | |
| TNQYNNPAGLYSSEN | 141 | O00151 | |
| PSPNQSYQGSSGYNF | 421 | O43189 | |
| QTQYSAGIQQATPYT | 71 | O00167 | |
| NSYYSSPAQQVPKNP | 236 | Q8NFQ8 | |
| HQQNYQPSQYSPKQQ | 271 | Q8N5C8 | |
| YQQYTQQSTLEPGPT | 361 | Q9Y519 | |
| PGMQSPSSYQNNNYG | 446 | Q9Y6Q9 | |
| QQQQYYSPQAQTPDQ | 376 | Q8ND83 | |
| QYNAQYSSASTPQYP | 246 | O95096 | |
| TYSQQQYPSQQSYPG | 326 | O75177 | |
| STCPPNGYFQYNTNV | 151 | O95498 | |
| EPYLSSQTNQSNSYP | 36 | Q7Z739 | |
| YQSGPIQSTTYTSQN | 571 | Q14157 | |
| QYSASYSQQTGPQQP | 271 | Q92734 | |
| NSQYGQQQDAYQGPP | 326 | Q15532 | |
| SSYQPTPTAGYQNVA | 661 | O14964 | |
| SSVQGNTYPSQAPVY | 466 | Q92783 | |
| PQYSYNNWSPPVQSN | 2436 | O00507 | |
| YTGPFSPGSAQYQQQ | 156 | Q9UGU0 | |
| SNPYITPNNRYGHQN | 356 | Q63HK5 | |
| PYLTGQSNQSNSYPS | 36 | Q9BYJ9 | |
| QSNQSNSYPSMSDPY | 41 | Q9BYJ9 |